{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:29:46Z","timestamp":1783499386028,"version":"3.55.0"},"reference-count":26,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.3201\/eid2209.152050","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T14:05:38Z","timestamp":1470837938000},"source":"Crossref","is-referenced-by-count":39,"title":["Use of Testing for West Nile Virus and Other Arboviruses"],"prefix":"10.3201","volume":"22","author":[{"given":"Jakapat","family":"Vanichanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrecia","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Wootton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa N.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy O.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Hasbun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2209.152050-201608101005-R1","first-page":"1","article-title":"Centers for Disease Control and Prevention. Surveillance for human West Nile virus disease\u2014United States, 1999\u20132008.","volume":"59","author":"Lindsey","year":"2010","journal-title":"MMWR Surveill Summ"},{"key":"key-10.3201\/eid2209.152050-201608101005-R2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3201\/eid1901.121135","article-title":"West Nile virus infection among humans, Texas, USA, 2002\u20132011.","volume":"19","author":"Nolan","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R3","first-page":"513","article-title":"West Nile virus and other arboviral diseases\u2014United States, 2012.","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2209.152050-201608101005-R4","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3201\/eid1911.130768","article-title":"West Nile virus, Texas, USA, 2012.","volume":"19","author":"Murray","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1086\/656602","article-title":"West Nile fever characteristics among viremic persons identified through blood donor screening.","volume":"202","author":"Zou","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","article-title":"Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.","volume":"358","author":"Mostashari","year":"2001","journal-title":"Lancet"},{"key":"key-10.3201\/eid2209.152050-201608101005-R7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.diagmicrobio.2013.11.006","article-title":"Clinical features of West Nile virus epidemic in Dallas, Texas, 2012.","volume":"78","author":"Racsa","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1086\/380458","article-title":"Severe West Nile virus disease in healthy adults.","volume":"38","author":"Emig","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1473-3099(15)00134-6","article-title":"Long-term sequelae of West Nile virus\u2013related illness: a systematic review.","volume":"15","author":"Patel","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R10","doi-asserted-by":"publisher","first-page":"e40374","DOI":"10.1371\/journal.pone.0040374","article-title":"Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort.","volume":"7","author":"Nolan","year":"2012","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2209.152050-201608101005-R11","doi-asserted-by":"publisher","first-page":"e102953","DOI":"10.1371\/journal.pone.0102953","article-title":"Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort.","volume":"9","author":"Murray","year":"2014","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2209.152050-201608101005-R12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1128\/JCM.42.2.727-733.2004","article-title":"Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation.","volume":"42","author":"Malan","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2209.152050-201608101005-R13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1017\/S0950268814000909","article-title":"Use of laboratory reports as predictors of West Nile virus disease cases, Texas, 2008\u20132012.","volume":"143","author":"Yendell","year":"2015","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid2209.152050-201608101005-R14","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1017\/S0950268811002494","article-title":"Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA.","volume":"140","author":"Weber","year":"2012","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid2209.152050-201608101005-R15","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1016\/j.vaccine.2007.04.058","article-title":"Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data.","volume":"25","author":"Tapiainen","year":"2007","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2209.152050-201608101005-R16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R17","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1056\/NEJMoa040845","article-title":"Clinical features and prognostic factors in adults with bacterial meningitis.","volume":"351","author":"van de Beek","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2209.152050-201608101005-R18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1086\/509330","article-title":"Beyond viruses: clinical profiles and etiologies associated with encephalitis.","volume":"43","author":"Glaser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R19","doi-asserted-by":"publisher","first-page":"e642","DOI":"10.1542\/peds.2014-0498","article-title":"Neuroinvasive arboviral disease in the United States: 2003 to 2012.","volume":"134","author":"Gaensbauer","year":"2014","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid2209.152050-201608101005-R20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1212\/01.wnl.0000195890.70898.1f","article-title":"CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis.","volume":"66","author":"Tyler","year":"2006","journal-title":"Neurology"},{"key":"key-10.3201\/eid2209.152050-201608101005-R21","first-page":"1103","article-title":"Cerebrospinal fluid analysis.","volume":"68","author":"Seehusen","year":"2003","journal-title":"Am Fam Physician"},{"key":"key-10.3201\/eid2209.152050-201608101005-R22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3201\/eid0903.020531","article-title":"Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases.","volume":"9","author":"Roehrig","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4269\/ajtmh.13-0232","article-title":"Persistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus.","volume":"89","author":"Murray","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2209.152050-201608101005-R24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jcv.2004.05.017","article-title":"Persistence of West Nile virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease.","volume":"31","author":"Kapoor","year":"2004","journal-title":"J Clin Virol"},{"key":"key-10.3201\/eid2209.152050-201608101005-R25","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1086\/591467","article-title":"Virus and antibody dynamics in acute West Nile virus infection.","volume":"198","author":"Busch","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2209.152050-201608101005-R26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3201\/eid2107.140858","article-title":"Assessment of arbovirus surveillance 13 years after introduction of West Nile virus, United States.","volume":"21","author":"Hadler","year":"2015","journal-title":"Emerg Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/9\/15-2050_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:28:12Z","timestamp":1732922892000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/9\/15-2050_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2209.152050","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}